Ident. | Authors (with country if any) | Title |
---|
000159 (2011) |
Keisuke Matsubara [Japon] ; Hiroshi Watabe [Japon] ; Yoshitaka Kumakura [Japon] ; Takuya Hayashi [Japon] ; Christopher J. Endres [États-Unis] ; Kotaro Minato [Japon] ; Hidehiro Iida [Japon] | Sensitivity of kinetic macro parameters to changes in dopamine synthesis, storage, and metabolism: A simulation study for [18F]FDOPA PET by a model with detailed dopamine pathway |
000230 (2011) |
Lucia Frau [Italie] ; Franco Borsini [Italie] ; Jadwiga Wardas [Pologne] ; Amit S. Khairnar [Italie] ; Nicoletta Schintu [Italie] ; Micaela Morelli [Italie] | Neuroprotective and anti‐inflammatory effects of the adenosine A2A receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease |
000514 (2010) |
Kevin St. P. Mcnaught [États-Unis] ; Ruth Jnobaptiste [États-Unis] ; Tehone Jackson [États-Unis] ; Toni-Ann Jengelley [États-Unis] | The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease |
000A22 (2009) |
Shin-Ichi Muramatsu [Japon] ; Tsuyoshi Okuno [Japon] ; Yutaka Suzuki [Japon] ; Takashi Nakayama [Japon] ; Takeharu Kakiuchi [Japon] ; Naomi Takino [Japon] ; Asako Iida [Japon] ; Fumiko Ono [Japon] ; Keiji Terao [Japon] ; Nobuo Inoue [Japon] ; Imaharu Nakano [Japon] ; Yasushi Kondo [Japon] ; Hideo Tsukada [Japon] | Multitracer assessment of dopamine function after transplantation of embryonic stem cell‐derived neural stem cells in a primate model of Parkinson's disease |
000B28 (2009) |
Zhen Qi [États-Unis] ; Gary W. Miller [États-Unis] ; Eberhard O. Voit [États-Unis] | Computational analysis of determinants of dopamine (DA) dysfunction in DA nerve terminals |
000E59 (2008) |
Anna R. Carta [Italie] ; Frau Lucia [Italie] ; Pinna Annalisa [Italie] ; Pontis Silvia [Italie] ; Simola Nicola [Italie] ; Schintu Nicoletta [Italie] ; Morelli Micaela [Italie] | Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6‐OHDA lesioned rat |
000F21 (2007) |
Qing-Jun Li [République populaire de Chine] ; Ya-Mei Tang [République populaire de Chine] ; Jun Liu [République populaire de Chine] ; Dao-You Zhou [République populaire de Chine] ; Xiang-Pen Li [République populaire de Chine] ; Song-Hua Xiao [République populaire de Chine] ; Dong-Xing Jian [République populaire de Chine] ; Yi-Gang Xing [République populaire de Chine] | Treatment of Parkinson disease with C17.2 neural stem cells overexpressing NURR1 with a recombined republic‐deficit adenovirus containing the NURR1 gene |
000F57 (2007) |
Margaret A. Piggott [Royaume-Uni] ; Clive G. Ballard [Royaume-Uni] ; Elise Rowan [Royaume-Uni] ; Clive Holmes [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] ; Evelyn Jaros [Royaume-Uni] ; Robert H. Perry [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni] | Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline |
000F78 (2007) |
Yuji Nagai [Japon] ; Shigeru Obayashi [Japon] ; Kiyoshi Ando [Japon] ; Motoki Inaji [Japon] ; Jun Maeda [Japon] ; Takashi Okauchi [Japon] ; Hiroshi Ito [Japon] ; Tetsuya Suhara [Japon] | Progressive changes of pre‐ and post‐synaptic dopaminergic biomarkers in conscious MPTP‐treated cynomolgus monkeys measured by positronemission tomography |
001124 (2007) |
Annalisa Pinna [Italie] ; Silvia Pontis [Italie] ; Franco Borsini [Italie] ; Micaela Morelli [Italie] | Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6‐hydroxydopamine rat model of Parkinson's disease |
001720 (2003) |
Elina Nurmi [Finlande] ; Jörgen Bergman [Finlande] ; Olli Eskola [Finlande] ; Olof Solin [Finlande] ; Tero Vahlberg [Finlande] ; Pirkko Sonninen [Finlande] ; Juha O. Rinne [Finlande] | Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET |
001808 (2003) |
Raúl De La Fuente-Fernández [Canada] ; Andrew S. Lim [Canada] ; Vesna Sossi [Canada] ; Michael J. Adam [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] ; Chong S. Lee [Canada] | Age and severity of nigrostriatal damage at onset of Parkinson's disease |
001990 (2001) |
Juha O. Rinne [Finlande] ; Elina Nurmi [Finlande] ; Hanna M. Ruottinen [Finlande] ; Jörgen Bergman [Finlande] ; Olli Eskola [Finlande] ; Olof Solin [Finlande] | [18F]FDOPA and [18F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease |
001992 (2001) |
Alan J. Fischman [États-Unis] ; Ali A. Bonab [États-Unis] ; John W. Babich [États-Unis] ; E. Livni [États-Unis] ; Nathaniel M. Alpert [États-Unis] ; Peter C. Meltzer [États-Unis] ; Bertha K. Madras [États-Unis] | [11C,127I] Altropane: A highly selective ligand for PET imaging of dopamine transporter sites |
001996 (2001) |
Masahiko Suzuki [États-Unis, Japon] ; Timothy J. Desmond [États-Unis] ; Roger L. Albin [États-Unis] ; Kirk A. Frey [États-Unis] | Vesicular neurotransmitter transporters in Huntington's disease: Initial observations and comparison with traditional synaptic markers |
001A17 (2001) |
Diana Frechilla [Espagne] ; Almudena Cobreros [Espagne] ; Laura Saldise [Espagne] ; Rosario Moratalla [Espagne] ; Ricardo Insausti [Espagne] ; M-Rosario Luquin [Espagne] ; Joaquín Del Río [Espagne] | Serotonin 5‐HT1A receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys |
001A85 (2001) |
Hanna M. Ruottinen [Finlande] ; Mikko Niinivirta [Finlande] ; Jörgen Bergman [Finlande] ; Vesa Oikonen [Finlande] ; Olof Solin [Finlande] ; Olli Eskola [Finlande] ; Esa Eronen [Finlande] ; Pirkko Sonninen [Finlande] ; Urpo K. Rinne [Finlande] | Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging |
001B69 (2000) |
Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grbois [Canada] ; Thérèse Di Paolo [Canada] | Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice |
001C20 (2000) |
Arpesh Mehta [États-Unis] ; Kyriaki Thermos [Grèce] ; Marie-Françoise Chesselet [États-Unis] | Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions |
001C40 (2000) |
J. M. Van Kampen [Canada] ; E. G. Mcgeer [Canada] ; A. Jon Stoessl [Canada] | Dopamine transporter function assessed by antisense knockdown in the rat: Protection from dopamine neurotoxicity |
001D61 (1999) |
Martin Goulet ; Marc Morissette ; Richard Grondin ; Pierre Falardeau ; Paul J. Bédard ; William Rostène [France] ; Thérèse Di Paolo | Neurotensin receptors and dopamine transporters: Effects of MPTP lesioning and chronic dopaminergic treatments in monkeys |
001D65 (1999) |
C. S. Biggs [Royaume-Uni] ; M. S. Starr [Royaume-Uni] | Microdialysis study of the effects of the antiparkinsonian drug budipine on L‐DOPA‐induced release of dopamine and 5‐hydroxytryptamine by rat substantia nigra and corpus striatum |
001E01 (1999) |
Yasushi Ito [Japon] ; Masahiro Fujita [Japon] ; Shoichi Shimada ; Yoshiyuki Watanabe [Japon] ; Tomoya Okada [Japon] ; Hideo Kusuoka [Japon] ; Masaya Tohyama [Japon] ; Tsunehiko Nishimura [Japon] | Comparison between the decrease of dopamine transporter and that of L‐DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models |
001E55 (1998) |
C. S. Biggs [Royaume-Uni] ; A. Fisher [Royaume-Uni] ; M. S. Starr [Royaume-Uni] | The antiparkinsonian drug budipine stimulates the activity of aromatic L‐amino acid decarboxylase and enhances L‐DOPA‐induced dopamine release in rat substantia nigra |
002047 (1997) |
Jean-Paul Soucy [Canada] ; Abdelghani Mrini [Canada] ; Francine Lafaille [Canada] ; Guy Doucet [Canada] ; Laurent Descarries [Canada] | Comparative evaluation of [3H]WIN 35428 and [3H]GBR 12935 as markers of dopamine innervation density in brain |
002055 (1997) |
Rafael Rodríguez-Puertas [Espagne] ; Julio Pascual [Espagne] ; Teresa Vilar [Espagne] ; Ángel Pazos [Espagne] | Autoradiographic distribution of M1, M2, M3, and M4 muscarinic receptor subtypes in Alzheimer's disease |
002300 (1995) |
Juha O. Rinne [Finlande] ; Arto Laihinen [Finlande] ; Kjell N Gren [Finlande] ; Hanna Ruottinen [Finlande] ; Ulla Ruotsawnen [Finlande] ; Urpo K. Rinne [Finlande] | PET examination of the monoamine transporter with [11c]β‐CIT and [11c]β‐CFT in early parkinson's disease |
002535 (1993) |
Philip Seeman [Canada] ; Hong-Chang Guan [Canada] ; Hubert H. M. Van Tol [Canada] ; Hyman B. Niznik [Canada] | Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata |
002719 (1991) |
Christian Waeber [Suisse] ; Monique Rigo [Suisse] ; Giorgia Chinaglia [Suisse] ; Alphonse Probst [Suisse] ; José M. Palacios [Suisse] | Beta‐adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease |